Medical Humanities Report


Second Cambridge Consortium for Bioethics Education

Center for Ethics Professor Leonard Fleck was recently invited to be a featured speaker at the Second Cambridge Consortium for Bioethics Education. The Consortium, a Cambridge University Press event, met April 11-13, 2012 at Reid Hall in Paris to further their goals of creating an international community of bioethics educators. The conference drew an audience of international bioethicists and featured speakers representing four continents. Dr. Fleck gave two lectures while there: "Mind the Ethical Gaps: What Do Our Students Learn?" and "The Social Context of Clinical Decision Making." To learn more about the Consortium, please visit their website.
The Ethical Challenges of Personalized Medicine

Leonard Fleck, Ph.D., Professor in the Center for Ethics and Humanities in the Life Sciences was recently interviewed on WNPR's Where We Live to offer the ethical perspective on genomic research and the prospective options for personalized medicine. The topic came up as a recent deal was made by the State of Connecticut to give Jackson Laboratories funds to build a new genomic research facility on the campus of the University of Connecticut. Read more or listen to the story 

"Living Cadavers" in Bangladesh: Bioviolence in the Human Organ Bazaar

A research study was recently published by Monir Moniruzzaman, assistant professor of Anthropology and the Center for Ethics and Humanities in the Life Sciences, in Medical Anthropology Quarterly. The study describes Moniruzzaman's work finding human organ trafficking victims, how they were coerced into the procedures, and the physical and emotional aftermath. 

Read an article describing Moniruzzaman's work on the MSU News site by Andy Henion, MSU University Relations. Additional articles available at The Atlantic and ABC News.
 


 

Site News

Extra Extra newspaper
LATEST Center News
An FDA advisory panel voted against the approval of Girosa, a pill also called 'female Viagra', which has been proposed to treat a decrease in a women's libido. How do you feel about the panel's recommendation?
 

Bioethics in the News Forum